Details for: CL0002045

Cell ID: CL0002045

Cell Name: fraction A pre-pro B cell

Description: Markers associated with mouse cells.

Synonyms: fraction A, pre pro B cell

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for fraction A pre-pro B cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for fraction A pre-pro B cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for fraction A pre-pro B cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for fraction A pre-pro B cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  fraction A pre-pro B cell (CL0002045)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [fraction A pre-pro B cell](/details-cell/CL0002045) represents one of the earliest committed progenitors in the B lymphocyte lineage. Analysis of its gene significance profile reveals that its identity is not defined by classic B-cell markers, but rather by the highly specific expression of genes integral to fundamental cellular processes. **Overall**, the top markers are dominated by genes involved in RNA processing, chromatin organization, and energy metabolism, such as [HMGB1](/details-gene/3146), [HNRNPC](/details-gene/3183), and [ATP5MC2](/details-gene/517). This molecular signature suggests a cell state primed for rapid biosynthesis and proliferation, poised at the cusp of differentiation. The lack of significant expression for key B-cell lineage factors like [PAX5](/details-gene/5079) further solidifies its status as a highly undifferentiated precursor. ## Key Characteristics and Function The functional profile of the [fraction A pre-pro B cell](/details-cell/CL0002045) is characterized by a state of high metabolic and biosynthetic activity, essential for its role as a progenitor. The most prominent gene signatures can be grouped into several key functional clusters: * **RNA and DNA Metabolism:** A substantial number of the most specific markers are involved in RNA binding, splicing, and processing. This includes multiple heterogeneous nuclear ribonucleoproteins like [HNRNPC](/details-gene/3183), [HNRNPA2B1](/details-gene/3181), and [HNRNPA1](/details-gene/3178), as well as other critical RNA/DNA binding proteins such as [HMGB1](/details-gene/3146), [NPM1](/details-gene/4869), and [YBX1](/details-gene/4904). This strong signature indicates that post-transcriptional gene regulation is a central feature of this cell, likely governing the precise expression programs required for subsequent developmental steps. * **Energy Production:** The cell exhibits a distinct signature of genes associated with mitochondrial respiration. High `csi_z` scores for components of the ATP synthase complex ([ATP5MC2](/details-gene/517), [ATP5MG](/details-gene/10632), [ATP5F1E](/details-gene/514)) and cytochrome c oxidase ([COX4I1](/details-gene/1327)) suggest a high demand for ATP produced via oxidative phosphorylation. This energetic state is likely necessary to fuel the intensive processes of cell division and protein synthesis. * **Chromatin Organization and Translation:** The specific expression of histone variants [H3 3A](/details-gene/3020) and [H3 3B](/details-gene/3021) points towards active chromatin remodeling, a necessity for a progenitor cell undergoing lineage commitment. Concurrently, high-ranking markers involved in translation, such as [EEF1D](/details-gene/1936) and [EEF1B2](/details-gene/1933), underscore the cell's high capacity for protein synthesis. * **Defining by Absence (Anti-Markers):** The identity of this cell is sharpened by the genes it does not specifically express. Crucially, canonical B-cell lineage markers, including the master regulator transcription factor [PAX5](/details-gene/5079), the B-cell co-receptor [CD22](/details-gene/933), and immunoglobulin heavy chain D ([IGHD](/details-gene/3495)), are found among the least significant genes. This molecular pattern is consistent with its pre-pro B cell status, a stage preceding the full activation of the B-lymphoid developmental program. ## Clinical Significance and Contextual Roles The gene profile of the [fraction A pre-pro B cell](/details-cell/CL0002045) highlights its nature as a rapidly dividing progenitor, and the dysregulation of its core pathways may have significant clinical implications. Several of its top markers are implicated in cancer. For instance, Nucleophosmin ([NPM1](/details-gene/4869)) is frequently mutated in acute myeloid leukemia, where it plays roles in ribosome biogenesis and the maintenance of genomic stability ([Link](https://pubmed.ncbi.nlm.nih.gov/2478125/)). Similarly, [HMGB1](/details-gene/3146), a key chromatin protein, can be released by cells and act as a damage-associated molecular pattern (DAMP) molecule, promoting inflammation and tumorigenesis in various contexts ([Link](https://doi.org/10.1002/(sici)1097-0215(19970220)74:1<1::aid-ijc1>3.0.co;2-6)). The high expression of these and other fundamental regulatory genes suggests that this early B-cell progenitor may be particularly vulnerable to oncogenic transformation. Mutations or expression changes in its core machinery for RNA processing, chromatin maintenance, or cell cycle control could potentially lock the cell in a proliferative state, contributing to the development of B-cell acute lymphoblastic leukemia (B-ALL). The cell's molecular signature, therefore, represents a baseline of high cellular activity that, if subverted, could lead to hematological malignancy. ## Potential Mechanisms and Research Directions 1. **Hypothesis:** The highly specific expression of a large cohort of heterogeneous nuclear ribonucleoproteins (hnRNPs), including [HNRNPC](/details-gene/3183), [HNRNPA1](/details-gene/3178), and [HNRNPA2B1](/details-gene/3181), acts as a primary regulatory layer that orchestrates the initial steps of B-lineage commitment. This hnRNP hub may control the alternative splicing and stability of key downstream transcription factor mRNAs, thereby priming the cell for differentiation before the transcription factors themselves become defining markers. * **Surprising Findings:** It is notable that the most defining characteristics of this progenitor cell are not lineage-specific transcription factors but rather general RNA-binding proteins. This suggests that post-transcriptional regulation may be a more critical gatekeeper at this very early developmental checkpoint than transcriptional initiation itself. * **Testable Questions:** Does the targeted knockdown of [HNRNPC](/details-gene/3183) in [fraction A pre-pro B cells](/details-cell/CL0002045) alter the splicing patterns of crucial early B-cell development genes (e.g., *EBF1*, *TCF3*) and subsequently block or delay their differentiation into pro-B cells upon cytokine stimulation? 2. **Hypothesis:** The distinct metabolic signature, marked by high specificity of mitochondrial respiratory chain components like [ATP5MC2](/details-gene/517) and [COX4I1](/details-gene/1327), indicates that a state of high oxidative phosphorylation (OXPHOS) is not merely supportive but instructive for maintaining the pre-pro B cell identity. This metabolic poise may be a prerequisite to meet the bioenergetic and biosynthetic demands of V(D)J recombination and the massive clonal expansion that follows successful gene rearrangement. * **Surprising Findings:** While many highly proliferative cells, including some cancer cells, rely heavily on aerobic glycolysis (the Warburg effect), this progenitor population's specific gene signature points emphatically towards mitochondrial respiration. This suggests that different metabolic strategies may be employed at distinct stages of lymphocyte development. * **Testable Questions:** How does the pharmacological inhibition of mitochondrial ATP synthase (e.g., with oligomycin) impact the survival, cell cycle progression, and differentiation potential of cultured [fraction A pre-pro B cells](/details-cell/CL0002045)?